Science and Transparency Over Politics Act This bill directs the Pandemic Response Accountability Committee to appoint a task force to investigate political interference with decisions made by scientific agencies of the Department of Health and Human Services during the COVID-19 (i.e., coronavirus disease 2019) emergency, such as pressure placed on the Food and Drug Administration to reach a certain outcome related to a drug or device to treat or prevent COVID-19. This committee, which is made up of inspectors general of certain federal agencies, conducts and supports oversight of the federal government's COVID-19 response efforts.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S5790)
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S5790)
Health
Accounting and auditingCardiovascular and respiratory healthCenters for Disease Control and Prevention (CDC)Congressional oversightDepartment of Health and Human ServicesEmergency medical services and trauma careFood and Drug Administration (FDA)Government ethics and transparency, public corruptionGovernment studies and investigationsHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesInfectious and parasitic diseasesMedical researchMedical tests and diagnostic methodsResearch administration and fundingResearch ethicsScientific communication
Science and Transparency Over Politics Act
USA116th CongressS-4638| Senate
| Updated: 9/22/2020
Science and Transparency Over Politics Act This bill directs the Pandemic Response Accountability Committee to appoint a task force to investigate political interference with decisions made by scientific agencies of the Department of Health and Human Services during the COVID-19 (i.e., coronavirus disease 2019) emergency, such as pressure placed on the Food and Drug Administration to reach a certain outcome related to a drug or device to treat or prevent COVID-19. This committee, which is made up of inspectors general of certain federal agencies, conducts and supports oversight of the federal government's COVID-19 response efforts.
Accounting and auditingCardiovascular and respiratory healthCenters for Disease Control and Prevention (CDC)Congressional oversightDepartment of Health and Human ServicesEmergency medical services and trauma careFood and Drug Administration (FDA)Government ethics and transparency, public corruptionGovernment studies and investigationsHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesInfectious and parasitic diseasesMedical researchMedical tests and diagnostic methodsResearch administration and fundingResearch ethicsScientific communication